Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Headquartered in Columbus, Ohio, Cardinal Health is a global, integrated healthcare services and products company that generated $205 billion in revenue in its fiscal year 2023. The company plays ...
Cardinal Health CEO Jason Hollar recounted the ... its profitable business delivering medical supplies for at-home care. Altogether the four acquisitions in 2024 total $6.2 billion.
Jefferies Financial Group upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The brokerage ...
Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, ...
Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...
Jan 30 (Reuters) - Drug distributor Cardinal Health (CAH.N), opens new tab said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect ...
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results